| Execution period | Permanent |
|---|
NSE filing, NSE: CAMS. Summary written from the filing by ALFA Finder's alert engine.
Computer Age Management Services Ltd: key numbers
- Share price
- ₹653.60
- Market cap
- ₹16,243 Cr
- Revenue (annual)
- ₹1,516 Cr
- Net profit (annual)
- ₹476.0 Cr
- P/E (TTM)
- 31.8×Sector 23.5×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 45.58%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Computer Age Management Services Ltd
All →Computer Age Management Services Earnings Call Transcript: Key Takeaways
CAMS successfully crossed the ₹400 Cr revenue mark, showing strong non-mutual fund scaling and solid EBITDA expansion despite significant platform modernization costs.
- Call
- Guides 30% growth
Computer Age Management Services Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹414.5 Cr (+10.0% YoY), EBITDA ₹190.9 Cr (46.0% margin), PAT ₹131.5 Cr (+14.4% YoY). MF AuM ₹58.4 lakh Cr, 67% share.
Computer Age Management Services Results Update
CAMS reported higher Q2 FY27 consolidated profit and recommended an interim dividend, with revenue and EBITDA both growing year on year. Management highlighted record mutual fund AuM and growth in non-mutual fund businesses.
Computer Age Management Services Dividend
Computer Age Management Services declared an interim dividend of Rs. 3.25 per equity share at its October 29, 2026 board meeting. The record date and payment date are not stated in the extract.
Computer Age Management Services Q2 FY27 Results: Net Profit ₹130.7 Cr, Up 14.7% YoY
Computer Age Management Services Ltd reported revenue from operations of ₹414.5 Cr (+10.0% YoY) and net profit of ₹130.7 Cr (+14.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹130.7 Cr · +14.7% YoY
Computer Age Management Services Employee Stock Options
CAMS allotted 7,130 equity shares to eligible employees under its ESOP Scheme 2019. Post-allotment, paid-up capital stands at 24.85 crore shares of Rs.2 each.
Other regulatory approval announcements
All →Nesco Regulatory Approval
Nesco Limited received a Commencement Certificate from BMC for Tower-2 and Hall-1 at Nesco Center, Goregaon. The company can now proceed with construction and development of the proposed projects, valid until 29 October 2027.
Grasim Industries Regulatory Approval
CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.
Vedavaag Systems Regulatory Approval
Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.
Hikal Regulatory Approval
Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.
Sun Pharmaceutical Industries Regulatory Approval
Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.
RNFI Services Regulatory Approval
RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.